Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.460.35%
QQQ
707.990.05%
BTC/USD
77340.980.0666%
DIA
529.490.33%
GLD
400.650.98%
TLT
81.880.01%

BioHarvest Sciences Inc

BHSTNASDAQ
Trade with Public
Trade with Public
$1.92
Last update: Sep 2, 1:15 PM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareStock Report

BioHarvest Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for BioHarvest Sciences (BHST).

Price Target Range — 4 Quarters

Analyst Consensus — 3 Analysts

3Buy
Consensus RatingBuy# Analysts3Avg. Consensus PT$9Upside to Avg. PT+368.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 12, 2026Maxim GroupAnthony VendettiPT CutBuy$12→$5
Aug 12, 2026Roth CapitalSean McGowanPT CutBuy$10→$8
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Maxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5

Maxim Group analyst Anthony Vendetti maintains BioHarvest Sciences (NASDAQ:BHST) with a Buy and lowers the price target from $12 to $5.
Benzinga Newsdesk

PRO
Roth Capital Maintains Buy on BioHarvest Sciences, Lowers Price Target to $8

Roth Capital analyst Sean McGowan maintains BioHarvest Sciences (NASDAQ:BHST) with a Buy and lowers the price target from $10 to $8.
Benzinga Newsdesk

This Tempus AI Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

PRO
Roth Capital Initiates Coverage On BioHarvest Sciences with Buy Rating, Announces Price Target of $10

Roth Capital analyst Sean McGowan initiates coverage on BioHarvest Sciences (NASDAQ:BHST) with a Buy rating and announces Price Target of $10.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioHarvest Sciences, Maintains $14 Price Target

HC Wainwright & Co. analyst Amit Dayal reiterates BioHarvest Sciences (NASDAQ:BHST) with a Buy and maintains $14 price target.
Benzinga Newsdesk

PRO
Maxim Group Initiates Coverage On BioHarvest Sciences with Buy Rating, Announces Price Target of $12

Maxim Group analyst Anthony Vendetti initiates coverage on BioHarvest Sciences (NASDAQ:BHST) with a Buy rating and announces Price Target of $12.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved